Evidence map›Paper›PMID 40718172›Full record

ArticleCureus2025

Evaluation of Cardiovascular Disease Risk According to the Morningness-Eveningness Status in Adult Individuals.

Ayfer Beyaz Coskun, Emine Elibol, Sehriban Duyar Ozer

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ayfer Beyaz CoskunNutrition and Dietetics, Firat University, Elazig, TUR.
Emine ElibolNutrition and Dietetics, Ankara Yıldırım Beyazıt Üniversitesi, Ankara, TUR.
Sehriban Duyar OzerNutrition and Dietetics, Hitit University, Corum, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Chronotype is the individual's tendency to exhibit morning or evening behaviors. Having an evening chronotype creates an environment for different chronic diseases. An individual's lifestyle behaviors that are contrary to the endogenous circadian rhythm pave the way for hypertension and other cardiovascular diseases (CVDs). Methods This study, which was conducted to evaluate the relationship between chronotype and CVD risk in adult individuals, involved a total of 1,100 individuals aged between 19 and 64 years who applied to a family health center in Elazig, Turkey. The demographic questionnaire, the self-assessment Morningness-Eveningness Questionnaire (MEQ), and the Framingham Risk Score were used to collect data. Biochemical parameters were queried from patient records with measurements taken in the last week, and anthropometric measurements were recorded by researchers. Results At the end of the study, it was determined that individuals in the eveningness group had a higher risk (N=31, 29.8%) of CVDs. In addition, the percentage of individuals with body mass index (BMI) (N=67, 64.4%), fasting blood glucose (FBG) (N=19, 18.3%), total cholesterol (N=44, 42.3%), and low-density lipoprotein cholesterol (LDL-c) (N=38, 36.5%) values ​​above the reference ranges was found to be higher in the evening chronotype group. Conclusion As a result, individuals with an evening chronotype are at higher risk for CVDs. In addition, obesity and some biochemical parameters are more common in individuals with an evening chronotype. Supporting healthy lifestyle activities by taking into account the chronotype habits of individuals may contribute to the prevention of chronic diseases.

Indexed as

anthropometrybiochemistrycardiovascular diseaseschronotypeexercisemorningness-eveningness statussleep

Identifiers

PMID40718172
PMCPMC12296398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.